Atrium Therapeutics, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
12.77
-0.22 (-1.69%)
At close: Apr 30, 2026, 4:00 PM EDT
12.96
+0.19 (1.49%)
After-hours: Apr 30, 2026, 4:16 PM EDT
Atrium Therapeutics Market Cap
Atrium Therapeutics has a market cap or net worth of $198.13 million as of April 30, 2026.
Market Cap
198.13M
Enterprise Value
205.21M
1-Year Change
n/a
Ranking
n/a
Category
Stock Price
$12.77
Market Cap Chart
Since February 27, 2026, Atrium Therapeutics's market cap has decreased from $228.80M to $198.13M, a decrease of -13.41%. That is a compound annual growth rate of -57.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 201.50M | 3.49% |
| Apr 28, 2026 | 194.70M | -2.70% |
| Apr 27, 2026 | 200.10M | -4.40% |
| Apr 24, 2026 | 209.30M | -2.61% |
| Apr 23, 2026 | 214.90M | 1.42% |
| Apr 22, 2026 | 211.90M | 0.95% |
| Apr 21, 2026 | 209.90M | -5.41% |
| Apr 20, 2026 | 221.90M | -0.76% |
| Apr 17, 2026 | 223.60M | 2.71% |
| Apr 16, 2026 | 217.70M | -3.50% |
| Apr 15, 2026 | 225.60M | 3.72% |
| Apr 14, 2026 | 217.50M | 5.43% |
| Apr 13, 2026 | 206.30M | 4.61% |
| Apr 10, 2026 | 197.20M | -7.37% |
| Apr 9, 2026 | 212.90M | 0.14% |
| Apr 8, 2026 | 212.60M | -2.07% |
| Apr 7, 2026 | 217.10M | 2.36% |
| Apr 6, 2026 | 212.10M | 1.73% |
| Apr 2, 2026 | 208.50M | -0.24% |
| Apr 1, 2026 | 209.00M | 0.77% |
| Mar 31, 2026 | 207.40M | -1.33% |
| Mar 30, 2026 | 210.20M | 2.39% |
| Mar 27, 2026 | 205.30M | 1.03% |
| Mar 26, 2026 | 203.20M | 0.05% |
| Mar 25, 2026 | 203.10M | -0.83% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 214.90M |
| MediWound | 210.39M |
| OmniAb | 204.14M |
| Replimune Group | 201.48M |
| Nkarta | 201.04M |
| Korro Bio | 195.14M |
| MacroGenics | 194.49M |
| Elicio Therapeutics | 194.08M |